Myocardial ischemia is a medical ailment characterized by a diminished supply of blood to the heart muscle, typically arising from the constriction or blockage of coronary arteries. This reduction in blood flow causes the heart muscle to be deprived of oxygen and essential nutrients, potentially resulting in damage or cell death. A primary contributor to myocardial ischemia is atherosclerosis, a condition where the coronary arteries narrow due to the accumulation of fatty deposits, cholesterol, and other substances. The symptoms of myocardial ischemia often manifest as angina, which is characterized by chest pain or discomfort. In severe instances, myocardial ischemia can progress to a heart attack. Prompt diagnosis and intervention play a pivotal role in managing myocardial ischemia and averting further complications. The emphasis lies on a multifaceted approach encompassing lifestyle modifications, medication, and, in certain cases, surgical interventions aimed at restoring blood flow and preserving optimal heart function. Timely and appropriate medical attention is imperative in addressing myocardial ischemia and preventing its progression to more severe cardiac events.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation